165 related articles for article (PubMed ID: 8698303)
1. Extraosseous primary and recurrent giant cell tumors: transforming growth factor-beta1 and -beta2 expression may explain metaplastic bone formation.
Teot LA; O'Keefe RJ; Rosier RN; O'Connell JX; Fox EJ; Hicks DG
Hum Pathol; 1996 Jul; 27(7):625-32. PubMed ID: 8698303
[TBL] [Abstract][Full Text] [Related]
2. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
Zheng MH; Fan Y; Wysocki SJ; Lau AT; Robertson T; Beilharz M; Wood DJ; Papadimitriou JM
Am J Pathol; 1994 Nov; 145(5):1095-104. PubMed ID: 7977641
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
4. TGF-β induced PAR-1 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone.
Wang T; Jiao J; Zhang H; Zhou W; Li Z; Han S; Wang J; Yang X; Huang Q; Wu Z; Yan W; Xiao J
Int J Cancer; 2017 Oct; 141(8):1630-1642. PubMed ID: 28670703
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart.
Mancini I; Righi A; Gambarotti M; Picci P; Dei Tos AP; Billings SD; Simi L; Franchi A
Histopathology; 2017 Sep; 71(3):453-460. PubMed ID: 28477388
[TBL] [Abstract][Full Text] [Related]
6. Bone formation zones in heterotopic ossifications: histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors beta2 and beta3.
Toom A; Arend A; Gunnarsson D; Ulfsparre R; Suutre S; Haviko T; Selstam G
Calcif Tissue Int; 2007 Apr; 80(4):259-67. PubMed ID: 17401695
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta isoform and receptor expression in giant cell tumor and giant cell lesions of bone.
Franchi A; Benvenuti S; Masi L; Malentacchi C; Arganini L; Brandi ML; Santucci M
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):170-5. PubMed ID: 11396635
[TBL] [Abstract][Full Text] [Related]
8. Primary giant cell tumor of soft tissues similar to bone giant cell tumor: A case report and literature review.
Rodríguez-Peralto JL; Lopez-Barea F; Fernandez-Delgado J
Pathol Int; 2001 Jan; 51(1):60-3. PubMed ID: 11148467
[TBL] [Abstract][Full Text] [Related]
9. Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors.
Agaimy A; Michal M; Stoehr R; Ferrazzi F; Fabian P; Michal M; Franchi A; Haller F; Folpe AL; Kösemehmetoğlu K
Mod Pathol; 2021 Aug; 34(8):1507-1520. PubMed ID: 33742141
[TBL] [Abstract][Full Text] [Related]
10. Identification of differentially expressed genes and their subpathways in recurrent versus primary bone giant cell tumors.
Chen S; Li C; Wu B; Zhang C; Liu C; Lin X; Wu X; Sun L; Liu C; Chen B; Zhong Z; Xu L; Li E
Int J Oncol; 2014 Sep; 45(3):1133-42. PubMed ID: 24969034
[TBL] [Abstract][Full Text] [Related]
11. Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone.
Lou Z; Yang Y; Ren T; Tang S; Peng X; Lu Q; Sun Y; Guo W
Med Oncol; 2013; 30(3):606. PubMed ID: 23690270
[TBL] [Abstract][Full Text] [Related]
12. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
[TBL] [Abstract][Full Text] [Related]
13. Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: possible involvement in CD68+ macrophage-like cell migration.
Zheng MH; Fan Y; Smith A; Wysocki S; Papadimitriou JM; Wood DJ
J Cell Biochem; 1998 Jul; 70(1):121-9. PubMed ID: 9632113
[TBL] [Abstract][Full Text] [Related]
14. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.
Huang L; Xu J; Wood DJ; Zheng MH
Am J Pathol; 2000 Mar; 156(3):761-7. PubMed ID: 10702390
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of transforming growth factor beta in giant cell tumor of bone.
Butler MG; Dahir GA; Schwartz HS
Cancer Genet Cytogenet; 1993 Apr; 66(2):108-12. PubMed ID: 8500096
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of transforming growth factor-beta II receptor is associated with that of p27KIP1 in giant cell tumor of bone: a possible link between transforming growth factor-beta and cell cycle-related protein.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Takahira T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2004 Jan; 35(1):61-8. PubMed ID: 14745726
[TBL] [Abstract][Full Text] [Related]
17. Primary giant cell tumor of soft tissues: a study of 22 cases.
Oliveira AM; Dei Tos AP; Fletcher CD; Nascimento AG
Am J Surg Pathol; 2000 Feb; 24(2):248-56. PubMed ID: 10680893
[TBL] [Abstract][Full Text] [Related]
18. [Collagens and growth factors in heterotopic ossification].
Bosse A; Wulf M; Wiethege T; Voss B; Müller KM
Pathologe; 1994 Aug; 15(4):216-25. PubMed ID: 7971796
[TBL] [Abstract][Full Text] [Related]
19. Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression.
Maroulakou IG; Shibata MA; Anver M; Jorcyk CL; Liu Ml; Roche N; Roberts AB; Tsarfaty I; Reseau J; Ward J; Green JE
Oncogene; 1999 Sep; 18(39):5435-47. PubMed ID: 10498897
[TBL] [Abstract][Full Text] [Related]
20. Giant cell tumor with secondary aneurysmal bone cyst: a unique presentation with an ossified extraosseous soft tissue mass.
Hong WS; Sung MS; Kim JH; Kim HM; Kim TK; Chung MH; Lim YS; Lim HW
Skeletal Radiol; 2013 Nov; 42(11):1605-10. PubMed ID: 23708046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
